Circulating Tumor DNA from Ascites as an alternative to tumor sampling for genomic profiling in ovarian cancer patients

Genomic testing is crucial for the management of ovarian cancer. DNA from biopsies at diagnostic laparoscopies or interval debulking surgery after neoadjuvant chemotherapy, has a high failure rate. At relapse, biopsies may not be feasible. The aim of our study was to evaluate the feasibility and use...

Descripción completa

Detalles Bibliográficos
Autores principales: Kfoury, Maria, Hazzaz, Reda El, Sanson, Claire, Durand, Felix Blanc, Michels, Judith, Blameble, Emeline Colomba, Tang, Roseline, Le Formal, Audrey, Lecerf, Elodie, Gouy, Sebastien, Maulard, Amandine, Pautier, Patricia, Rouleau, Etienne, Leary, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588202/
https://www.ncbi.nlm.nih.gov/pubmed/37858195
http://dx.doi.org/10.1186/s40364-023-00533-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588202/
https://www.ncbi.nlm.nih.gov/pubmed/37858195
http://dx.doi.org/10.1186/s40364-023-00533-1

Ejemplares similares